Clinical Trial Update: InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and Zambia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for InvaplexAR-Detox and DmLT Adjuvant conducting recruitment in the Netherlands and Zambia for shigellosis and bacillary dysenter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacillary Dysentery
• Shigellosis

Drugs mentioned

• DmLT Adjuvant
• InvaplexAR-Detox

Snippet

Sponsor: Leiden University Medical Center | Conditions: Shigellosis, Bacillary Dysentery | Phase 1 | Status: RECRUITING